anti-ALS antibodies (Trans Chromosomics/Order-Made Medical Research/Mitsubishi Tanabe)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-ALS antibodies (Trans Chromosomics/Order-Made Medical Research/Mitsubishi Tanabe)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrder-Made Medical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrder-Made Medical Research IncTrans Chromosomics CoMitsubishi Tanabe Pharma Corp
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A